Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes.

Cancer - 1 Oct 2009

Bacher Ulrike, Haferlach Torsten, Kern Wolfgang, Weiss Tamara, Schnittger Susanne, Haferlach Claudia

Abstract excerpt

BACKGROUND: Because of limited reproducibility of morphologic features, the morphological categorization of initial myelodysplastic syndromes (MDS) cases remains a major task in a diagnostic setting. METHODS: To further evaluate the role of additional diagnostic methods for suspected early MDS, the authors analyzed 1965 cases with unclear cytopenia where at least cytomorphology and immunophenotyping were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Chromosome Aberrations

Share to Immunophenotyping

Share to Myelodysplastic Syndromes

Share to Nucleophosmin

Source

Identifiers

PMID: 19569249
DOI: 10.1002/cncr.24501

Genes

NPM1
NRAS
RUNX1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes.PMID 19569249Read ↗

The Significance of Detecting an Unusual Myeloblast Immunophenotype in a Presumptive Clinical Diagnosis of Myelodysplastic Syndromes.Semantic proximity Read ↗

Advances in myelodysplastic/myeloproliferative neoplasms.Semantic proximity Read ↗

Where Does Morphology Fit in Myelodysplastic Syndrome Diagnosis in the Era of Molecular Testing?Semantic proximity Read ↗

The Use of Flow Cytometry in Myelodysplastic Syndromes: A ReviewSemantic proximity Read ↗

Pathogenic Mutations and Atypical Flow Cytometric Findings Characterize the Majority of Unclassifiable Myelodysplastic/Myeloproliferative Neoplasms.Semantic proximity Read ↗

The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm.Semantic proximity Read ↗

Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing?Semantic proximity Read ↗

Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.Semantic proximity Read ↗

The Challenging World of Cytopenias: Distinguishing Myelodysplastic Syndromes From Other Disorders of Marrow FailureSemantic proximity Read ↗

Diagnosis of myelodysplastic syndromes: the classic and the novelSemantic proximity Read ↗

Morphologic findings and mutational profiles of myelodysplastic neoplasms with normal versus abnormal karyotype.Semantic proximity Read ↗

Serial assessment of suspected myelodysplastic syndromes: significance of flow cytometric findings validated by cytomorphology, cytogenetics, and molecular geneticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.